Skip to main content
TipRanks
Go Ultimate75% OFF

Arkema SA (ARKAY) AI Stock Analysis

36 Followers
ARKAY

Arkema SA

(Other OTC:ARKAY)

Select Model
Rating:50Neutral
Price Target:$65.00â–²(2.28% Upside)
Action:reiterated
Date:11/11/26

The overall score reflects a company in transition, balancing significant financial headwinds with positive strategic execution. The primary drag is the severe deterioration in profitability and cash flow, which results in a very poor valuation score. However, the earnings call provides a counterbalance, with management demonstrating resilient Specialty Materials growth, cost discipline, and maintained guidance. Technicals are neutral, offering no strong directional signal. The high dividend yield is a potential support but carries risk given the weak underlying financials.

Positive Factors
Specialty Materials mixA high contribution from Specialty Materials and continued volume growth indicate a stronger mix of differentiated products. Innovation and customer adoption in demanding applications can support more resilient earnings and improve the company’s competitive position over the next several quarters.
Negative Factors
Compressed profitabilityVery low net profitability and the sharp decline in net income show that revenue has not translated efficiently into earnings. Weak bottom-line conversion reduces internal funding capacity and leaves results more exposed to further cost pressure or slower demand.

Arkema SA (ARKAY) vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%25%30%35%ARKAY+13.74%SPY+13.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$4.82B
Dividend Yield
6.87%
Average Volume (3M)
1,198
Price to Earnings (P/E)
52.5
Beta (1Y)
0.81
Revenue Growth
3.38%
EPS Growth
-39.63%
Country
US
Employees
20,648
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Arkema SA Business Overview & Revenue Model

Company Description

Arkema S.A. operates as a global producer and distributor of specialty chemicals and advanced materials. Its operations are strategically divided into four key business segments: Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermed...

How the Company Makes Money

Arkema makes money primarily by selling specialty chemicals and advanced materials to industrial customers under supply contracts and purchase orders, with revenue largely tied to shipment volumes and contract/market-based pricing. Key revenue stream...

Arkema SA Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|% Change Since:-2.22%|Next Earnings Date:Feb 25, 2027
Earnings Call SentimentPositive

The call was broadly positive. Arkema delivered 8.1% sales growth, 7% EBITDA growth, 23% adjusted EPS growth, strong Specialty Materials performance, cost savings and maintained full-year guidance despite weak demand, inflation, geopolitical pressures and low-cycle conditions in acrylics. The principal negatives were subdued European and construction demand, declines in Primary Materials and Performance Additives, elevated working-capital needs and leverage, and slower-than-normal project ramp-up.

Positive Updates

Q3 Sales Growth
Q3 sales reached EUR 2.4 billion, up 8.1% year-on-year, driven primarily by a positive 6% price effect, while volumes increased 0.6% and currency had a positive 1.8% impact.

Negative Updates

Challenging Macroeconomic Environment
Management described the third-quarter environment as challenging, with sharply higher oil, raw-material, energy and logistics costs following renewed tension in the Middle East, alongside low visibility and weak demand.

Company Guidance

Arkema remains confident in its ability to deliver full year guidance with EBITDA slightly higher than last year at constant currency; major projects are expected to contribute an additional EUR 50 million of EBITDA in 2026 compared with last year, while CapEx is expected to be below EUR 600 million for the full year. The company expects inflation to have an adverse impact of around EUR 150 million on working capital for the full year 2026, and expects a little bit better ratio by year-end for leverage. For next year, there was no further CapEx update, though something quite similar could be expected, while project contributions could be around EUR 50 million if there is a continuation of the macro, or EUR 60 million, EUR 70 million, EUR 80 million if the macro is better; compared to the end of '24, Arkema plans to add the EUR 400 million that it has defined.

Arkema SA Financial Statement Overview

Summary

Financial performance is under significant pressure. The income statement shows a sharp drop in profitability with a collapsing net margin, the balance sheet reflects a dramatic decline in return on equity, and cash flow generation has weakened considerably with shrinking free cash flow. The recent return to top-line growth is a positive signal but has not yet translated into improved earnings or cash flow.

Income Statement

28Negative

Balance Sheet

45Neutral

Cash Flow

35Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.09B8.71B9.54B9.51B11.55B9.52B
Gross Profit1.60B1.55B1.94B1.96B2.58B2.14B
EBITDA1.22B1.20B1.31B1.41B1.97B2.54B
Net Income83.99M60.51M354.00M418.00M965.00M1.31B
Balance Sheet
Total Assets14.40B14.24B15.21B14.52B13.51B12.30B
Cash, Cash Equivalents and Short-Term Investments1.56B2.20B2.01B2.04B1.59B2.29B
Total Debt5.13B5.36B4.55B4.28B3.26B2.76B
Total Liabilities7.92B8.01B7.45B7.06B6.17B5.95B
Stockholders Equity6.24B6.04B7.53B7.20B7.30B6.30B
Cash Flow
Free Cash Flow298.43M323.70M353.00M593.00M766.00M152.00M
Operating Cash Flow837.41M934.60M1.12B1.27B1.50B915.00M
Investing Cash Flow-542.81M-591.69M-940.00M-1.35B-2.34B473.00M
Financing Cash Flow-719.95M-251.66M-207.00M516.00M168.00M-652.00M

Arkema SA Technical Analysis

Technical Analysis SentimentNegative
Last Price63.55

Price Trends

50DMA63.47Positive
100DMA65.27Negative
200DMA66.06Negative

Market Momentum

MACD0.39Negative
RSI49.01Neutral
STOCH17.52Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARKAY, the sentiment is Negative. The current price of 63.55 is above the 20-day moving average (MA) of 63.36, above the 50-day MA of 63.47, and below the 200-day MA of 66.06, indicating a neutral trend. The MACD of 0.39 indicates Negative momentum. The RSI at 49.01 is Neutral, neither overbought nor oversold. The STOCH value of 17.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ARKAY.

Arkema SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

ARKAY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AVNTAVNT70Outperform$3.99B22.197.52%2.53%5.24%58.61%
FULFUL68Neutral$2.57B13.149.51%2.03%1.48%72.33%
EMNEMN65Neutral$7.13B11.0110.63%5.39%0.40%-6.58%
ESIESI62Neutral$7.72B37.557.39%1.01%39.62%-14.83%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
ASHASH61Neutral$3.40B820.670.21%2.25%2.08%―
ARKAYARKAY50Neutral$4.87B52.501.28%6.87%3.38%-39.63%

* Basic Materials Sector Average

Performance Comparison

0%50%100%ARKAYASHEMNFULAVNTESIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
ARKAY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ARKAYArkema S.A.63.558.7415.94%
ASHAshland Global Holdings, Inc.74.1527.2858.21%
EMNEastman Chemical Company62.308.6116.05%
FULH.B. Fuller Company47.79-6.69-12.28%
AVNTAvient Corporation43.5416.9063.42%
ESIElement Solutions31.829.0539.73%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 11, 2026